Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study

Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study

Abstract Background Risk of myocardial infarction (MI) is elevated in ankylosing spondylitis and psoriatic arthritis (AS/PsA) compared to the general population. We evaluated the risk of MI related to the use of tumor necrosis factor inhibitor (TNFi) and other therapies in AS/PsA. Methods We conduct...

Full description

Bibliographic Details
Main Authors: Rachael Stovall, Christine Peloquin, David Felson, Tuhina Neogi, Maureen Dubreuil
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Rheumatology
Subjects:
Ankylosing spondylitis
Psoriatic arthritis
Tumor necrosis factor inhibitors
Myocardial infarction
Online Access:https://doi.org/10.1186/s41927-021-00207-1

Internet

https://doi.org/10.1186/s41927-021-00207-1

Similar Items